13. October 2025

No compensation for isolation without possible vaccination – OPPENLÄNDER Rechtsanwälte wins for the state of Baden-Württemberg

On October 9, 2025, the Federal Administrative Court ruled that an employed person who was in quarantine in October 2021 due to infection with the coronavirus and thus suffered a loss of earnings cannot claim compensation from the state under the Infection Protection Act if they did not take advantage of the vaccination publicly recommended at the time despite having sufficient opportunity to do so.

The lower courts had ruled otherwise and ordered the state to pay compensation. The Administrative Court of Baden-Württemberg (VGH) had assumed that the plaintiff “could have avoided” isolation by getting vaccinated within the meaning of Section 56 (1) sentence 4 IfSG. This was because the VGH believed that isolation could only have been avoided by taking the vaccination if the vaccination had been “highly likely” to prevent infection. According to the VGH, this would require the vaccination to be “90 percent” effective against infection, or at least not significantly less than that. In October 2021, the COVID-19 vaccination had an efficacy of approximately 72 percent.

The Federal Administrative Court upheld the appeal by the state of Baden-Württemberg, overturned the lower court rulings, and dismissed the action. The plaintiff could have avoided infection and isolation within the meaning of the provision, insofar as the vaccination was effective (also) against infection with the virus. The possibility of avoiding infection was sufficient for it to be considered avoidable.

OPPENLÄNDER Rechtsanwälte represented the state of Baden-Württemberg in the proceedings. The following lawyers were involved: Dr. Malte Weitner (litigation, state liability, IfSG), Dr. Maximilian Stützel (public law, constitutional law).

Dr. Maximilian Stützel und Dr. Malte Weitner stehen vor dem Bürogebäude von OPPENLÄNDER Rechtsanwälte.

More news

04. June 2026

OPPENLÄNDER is strengthening its Intellectual Property and Healthcare practice with the addition of attorney Dr. Sonja Bühler, LL.M. (Edinburgh)

Dr. Sonja Bühler joined our Intellectual Property and Healthcare team in June 2026.

Read more
13. May 2026

OPPENLÄNDER wins lawsuit regarding claims for damages arising from pharmaceutical rebate contracts

Dr Matthias Ulshöfer and Dr Joachim Ott have successfully defended an international pharmaceutical company against unjustified claims for damages arising from pharmaceutical rebate contracts in a landmark case before the Munich Social Court. The actions brought by a major statutory health insurance fund were dismissed by way of a “judgment from the bench”.

Read more
01. April 2026

OPPENLÄNDER overturns minimum fares for ride-hailing services in Essen in a landmark case for BOLT

Dr. Henrike Schulte and Dr. Maximilian Gerhold of OPPENLÄNDER successfully secured a stay of a general administrative act issued by the City of Essen regarding minimum fares for ride-hailing services before the Administrative Court of Gelsenkirchen, acting on behalf of the European mobility platform BOLT and a Dortmund-based ride-hailing company.

Read more
12. February 2026

OPPENLÄNDER is once again among the best according to Legal500

In the recently published ranking of Legal 500 Germany 2026, we are once again a TOP LAW FIRM in the City Focus Stuttgart and are ranked as a TOP TIER LAW FIRM in two practice areas.

Read more